Skip to main content

US ClosedU.S. Closed

CMND: Clearmind Medicine Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments.

52W Range

0thpctl

Volume

0.01×avg

Market Cap

2.61MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Clearmind Medicine Inc.

CMNDNASDAQ Capital Market·USD·Closed

Clearmind Medicine Inc.

CMNDNASDAQ·USD·Closed

$1.76

−2.76%

$1.76

−$0.05 (2.76%)

52W Range

0thpctl

Volume

0.01×avg

Mkt Cap

2.61MUSD

P/E

-0.2TTM

Div Yield

–ann